Rechallenging clozapine after neuroleptic malignant syndrome

Psychiatric Quarterly

Volumn 85, Issue 3, 2014, Pages 345-348

  Anbalagan, Emaya ^a   Ithman, Muaid ^a   Lauriello, John ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Clozapine; Neuroleptic malignant syndrome; Side effects

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; CASE REPORT; FEMALE; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOTIC DISORDERS; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 84905900533     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-014-9291-9     Document Type: Article

References (11)

1. Amore M, Zazzeri N, Berardi D: Atypical neuroleptic malignant syndrome associated with Clozapine treatment. Neuropsychobiology 35(4):197-199, 1997 (Pubitemid 27212158)
2. Manu P, Sarpal D, Muir O, Kane JM, Correll CU: When can patients with potentially life-threatening adverse effects be rechallenged with Clozapine? A systematic review of the published literature. Schizophrenia Research 134(2-3):180-186, 2012. doi:10.1016/j.schres.2011.10.014
3. Susman VL, Addonizio G: Recurrence of neuroleptic malignant syndrome. The Journal of Nervous and Mental Disease 176(4):234-241, 1988
4. Pope HG, Jr., Cole JO, Choras PT, Fulwiler CE: Apparent neuroleptic malignant syndrome with Clozapine and lithium. The Journal of Nervous and Mental Disease 174(8):493-495, 1986 (Pubitemid 16040144)
5. Halman M, Goldbloom DS: Fluoxetine and neuroleptic malignant syndrome. Biological Psychiatry 28(6):518-251, 1990
6. Wilhelm K, Curtis J, Birkett V, Kenney-Herbert J: The clinical significance of serial creatine phosphokinase estimations in acute ward admissions. Australian and New Zealand Journal of Psychiatry 28(3):453-457, 1994 (Pubitemid 24360893)
7. Tsai G, Crisostomo G, Rosenblatt ML, Stern TA: Neuroleptic malignant syndrome associated with clozapine treatment. Annals of Clinical Psychiatry 7(2):91-95, 1995
8. Huang TL: Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Medical Journal 24(8):522-525, 2001
9. Anderson ES, Powers PS: Neuroleptic malignant syndrome associated with clozapine use. Journal of Clinical Psychiatry 52(3):102-104, 1991
10. Goates MG, Escobar JI: An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapinetherapy: report of a case and results of a clozapine rechallenge. Journal of Clinical Psychopharmacology 12(2):139-140, 1992
11. Chatterton R, Cardy S, Schramm TM: Neuroleptic malignant syndrome and clozapine monotherapy. Australian and New Zealand Journal of Psychiatry 30(5):692-693, 1996 (Pubitemid 26360031)